Recent News

• 03.07.2025 - argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
• 03.07.2025 - argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
• 02.27.2025 - argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
• 02.27.2025 - argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
• 02.25.2025 - argenx to Present at TD Cowen 45th Annual Healthcare Conference
• 02.25.2025 - argenx to Present at TD Cowen 45th Annual Healthcare Conference
• 02.20.2025 - argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
• 02.20.2025 - argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
• 01.13.2025 - argenx Highlights 2025 Strategic Priorities
• 01.13.2025 - argenx Highlights 2025 Strategic Priorities

Recent Filings

• 02.27.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.27.2025 - EX-99.1 EX-99.1
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]